99mTc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease

American Journal of Geriatric Psychiatry

Volumn 18, Issue 11, 2010, Pages 959-972

  Devanand, D P ^f   Van Heertum, Ronald L ^c   Kegeles, Lawrence S ^f   Liu, Xinhua ^b   Jin, Zong Hao ^f   Pradhaban, Gnanavalli ^f   Rusinek, Henry ^d   Pratap, Mali ^a   Pelton, Gregory H ^f   Prohovnik, Isak ^e   Stern, Yaakov ^c   Mann, J John ^a   Parsey, Ramin ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Mailman School of Public Health ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f NONE

Author keywords

Alzheimer disease; clinical utility; Mild cognitive impairment; prediction; SPECT

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL TRIAL; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; IMAGE ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING; SOCIAL STATUS; TEMPORAL LOBE; UNIVERSITY; VERBAL MEMORY;

EID: 78149282345     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181ec8696     Document Type: Article

References (41)

1. Minino AM, Heron MP, Murphy SL, et al: Deaths: final data for 2004. Natl Vital Stat Rep 2007;55:1-119
2. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
3. Erratum in Arch Neurol 1999;56:760
4. Devanand DP, Liu X, Tabert MH, et al: Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008;64:871-879
5. De Santi S, de Leon MJ, Rusinek H, et al: Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 2001. 2001;22:529-539
6. Devanand DP, Pradhaban G, Liu X, et al: Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007;68:828-836
7. Silverman DH, Small GW, Chang CY, et al: Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001;286:2120-2127
8. Mosconi L, Tsui WH, Herholz K, et al: Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 2008;49:390-398
9. Mosconi L, Tsui WH, De Santi S, et al: Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 2005;64:1860-1867
10. Chetelat G, Desgranges B, De La Sayette V, et al: Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374-1377
11. Drzezga A, Lautenschlager N, Siebner H, et al: Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 2003;30:1104-1113
12. Minoshima S, Giordani B, Berent S, et al: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94
13. Huang C, Wahlund LO, Svensson L, et al: Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2002;2:9-16
14. Johnson KA, Moran EK, Becker JA, et al: Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry 2007;78:240-247
15. Borroni B, Anchisi D, Paghera B, et al: Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006;27:24-31
16. Dougall NJ, Bruggink S, Ebmeier KP: Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004;12:554-570
17. Huang C, Wahlund LO, Almkvist O, et al: Voxel-and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003;19:1137-1144
18. Høgh P, Teller AS, Hasselbalch S, et al: Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: a comparative study. Dement Geriatr Cogn Disord 2007;24:429-433
19. Stern Y, Andrews H, Pittman J, et al: Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49:453-460
20. Tabert MH, Manly JJ, Liu X, et al: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006;63:916-924
21. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
22. Devanand DP, Pelton GH, Zamora D, et al: Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Arch Neurol 2005;62:975-980
23. Pfeffer RI, Kurosaki TT, Harrah CH Jr, et al: Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329
24. Tabert MH, Albert SM, Borukhova-Milov L, et al: Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758-764
25. Fallon BA, Keilp J, Prohovnik I, et al: Regional cerebral blood flow and cognitive deficits in chronic Lyme disease. J Neuropsychiatry Clin Neurosci 2003;15:326-332
26. Meltzer CC, Kinahan PE, Greer PJ, et al: Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 1999;40:2053-2065
27. Ishii K, Kanda T, Uemura T, et al: Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. Eur J Nucl Med Mol Imaging 2009;36:831-840
28. Reiman EM, Chen K, Alexander GE, et al: Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 2005;102:8299-8302
29. Yuan Y, Gu ZX, Wei WS: Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. Am J Neuroradiol 2009;30:404-410
30. Landau SM, Harvey D, Madison, et al: the Alzheimer's Disease Neuroimaging Initiative. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging, in press
31. Gsell W, De Sadeleer C, Marchalant Y, et al: The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J Chem Neuroanat 2000;20:215-224
32. Okamura N, Arai H, Maruyama M, et al: Combined analysis of CSF tau levels and [(123) I]iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002;159:474-476
33. Encinas M, De Juan R, Marcos A, et al: Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging 2003;30:1473-1480
34. Borroni B, Perani D, Broli M, et al: Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. J Neurol 2005;252:1359-1362
35. Hirao K, Ohnishi T, Hirata Y, et al: The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005;28:1014-1021
36. Huang C, Eidelberg D, Habeck C, et al: Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol Aging 2007;28:1062-1069
37. Gabryelewicz T, Pawlowska-Detko A, Mísko J, et al: Prediction of deterioration of mild cognitive impairment with CT and SPECT. Med Sci Monit 2007;13(suppl 1):31-37
38. Caroli A, Testa C, Geroldi C, et al: Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J Neurol 2007;254:1698-1707
39. Caffarra P, Ghetti C, Concari L, et al: Differential patterns of hypoperfusion in subtypes of mild cognitive impairment. Open Neuroimag J 2008;2:20-28
40. Nobili F, De Carli F, Frisoni GB, et al: SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment. J Alzheimers Dis 2009;17:761-772
41. Habert MO, Horn JF, Sarazin M, et al: Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment. Neurobiol Aging, in press